Skip to main content

i-sense likes...

Home > News > Isense Likes

Trial shows universal ‘test and treat’ policy alone is not enough to reduce HIV transmission

Results from a major five-year trial in South Africa show that rolling-out universal test and treat policy without innovation to better link people to treatment is unlikely to reduce the number of new HIV infections.

The Treatment as Prevention (TasP) trail was run by the Africa Health Research Institute (AHRI) in partnership with the French Agency for Research on AIDS and Viral Hepatitis (ANRS) in the Hlabisa area of northern KwaZulu-Natal between March 2012 and April 2016. The trial offered repeat home testing and immediate antiretroviral treatment in trial clinics for those who tested positive. The results, published in scientific journal The Lancet HIVon 1 December, show while there is good take-up of the offer of HIV screening at home – very few of those diagnosed with HIV sought treatment. Because their entry into the healthcare system was infrequent and slow, HIV transmission in the population was not reduced.

The AHRI call for expressions of interest

South Africa’s new leading research centre and i-sense partner, the Africa Health Research Institute (AHRI), is calling for expression of interests from outstanding candidates who wish to join them across a range of disciplines within HIV and TB research.

Leading Biomedical Research Institutes team up in the fight against HIV and TB in South Africa

i-sense partner the Africa Centre for Population Health have teamed up with The KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) to create the new Africa Health Research Institute.

mHealth for HIV Treatment & Prevention: A Systematic Review of the Literature

This systematic review assesses the published literature to describe the landscape of mobile health technology (mHealth) for HIV/AIDS and the evidence supporting the use of these tools to address the HIV prevention, care, and treatment cascade.

Africa Centre Professor Frank Tanser receives prestigious award for cutting-edge HIV research

Professor Frank Tanser, from i-sense partner institution the Africa Centre for Population Health, has been awarded a prestigious five-year National Institutes of Health (NIH) multi-million rand grant, as part of a multisdisciplinary HIV intervention research team targeting epidemics in Southern Africa.

QMUL Engagement & Enterprise award given to innovative eSexual Health Clinic project

Professor Claudia Estcourt and the eSTI2 Consortium have received the QMUL Engagement & Enterprise Proof of Concept Project Award for their innovative online clinical care pathway, rapidly linking people who have taken chlamydia tests to results and treatment.

Alan Turing Institute call for Expressions of Interest in Early Career Research Positions

The Institute will begin its scientific programmes in September 2015 and will be seeking applications from outstanding postdoctoral researchers across the globe to join them.

Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study

i-sense partners Public Health England and London School of Hygiene and Tropical Medicine investigate the cost effectiveness of flu vaccination strategies.

UK opens £70M 5G research facility; Operators pledge commitment

i-sense partner, the University of Surrey, opened the “world’s largest academic 5G innovation centre” (5GIC) in the UK, which will see the country’s current four operators collaborate on development of the technology.

EU Countries’ mHealth App Market Ranking 2015

Which EU countries are best for doing mHealth business? A benchmarking analysis of 28 EU countries about their market readiness for mHealth business/

Doctors prescribing antibiotics for gonorrhea that no longer work

The challenge of AMR continues as poor antibiotic stewardship increases the chances that drug-resistant forms of Gonorrhoea will spread. Study led by Public Health England. Original BMJ Article here.

EU and Japan announce cooperation on 5G mobile technology

During the 2015 EU-Japan summit, both parties have announced a milestone agreement in the global race to develop 5G mobile technology. The EU and Japan have agreed to join forces to cope with the increasing need for wireless Internet, bringing new functionalities and applications for the benefits of economies and societies.

Target Product Profile: HIV Self-Test

White paper on the evaluation of current HIV rapid tests and development of core specifications for next-generation HIV tests. Work funded by a grant from the Bill and Melinda Gates Foundation.

Supervised and Unsupervised Self-Testing for HIV in High- and Low-Risk Populations: A Systematic  Review

i-sense Deputy Director, Rosanna Peeling leads PLOS Medicine review on supervised (self-testing and counselling aided by a health care professional) and unsupervised (performed by self-tester with access to phone or internet counselling) self-testing strategies.

HIV Self-Testing in Resource-Limited Settings: Regulatory and Policy Considerations

This commentary, co-authored by i-sense's Rosanna Peeling, examines regulatory and policy issues with HIV self-testing, given its increased prominence as a potential part of the global HIV/AIDS response.

Power to the Patient

A report from The Economist Intelligence Unit on how mobile technology is transforming healthcare

Roche and Qualcomm in digital health alliance

Roche has formed an alliance with Qualcomm to develop remote patient-monitoring systems in the latest sign of digital technology beginning to transform healthcare, the Financial Times reports.

To predict flu outbreak, just Google it

Researchers at the University of California, say the combo of Google and CDC data could do better than predict U.S. flu levels in real-time — it could forecast a week into the future. IEEE Specrtrum reports. 

Longitude Prize 2014

How can we prevent the rise of resistance to antibiotics? Longitude Prize is looking to help tackle the problem with a £10 million prize fund for a diagnostic tool that can rule out antibiotic use or help identify an effective antibiotic to treat a patient. Register now and help to change the world.

What does the digital age mean for the public’s health?

Public Health England's Kevin Fenton discusses how digital health, particularly mobile health, opens up new possibilities for supporting people to protect and improve their health.

The flu detectives: solving a crime before it happens

Public Health England's Head of flu surveillance and i-sense Deputy Director, Richard Pebody, explains the truth behind the media coverage on this year's flu season, including mutating strains and vaccination. 

New Results from Flusurvey

The UK's largest crowd-sourced study of influenza, and i-sense collaborator, announce the latest results of their online participatory flu monitoring platform

mHealth for Ebola: Blueprint for Ebola Mobile Response from GSMA

The GSMA, through its Mobile for Development mHealth and Disaster Response programmes, has developed the Ebola Mobile Response, providing their network platforms for a coordinated and effective response to the current Ebola outbreak 

Ebola: Can big data analytics help contain its spread?

The BBC talks to big data scientists including i-sense partner Telefonica, on how big data analytics can significantly help in the struggle to contain the ebola virus, having already been successfully applied to some of the biggest global health crises to date. 

CDC tracks mobile phone location data to halt ebola 

The Centers for Disease Control and Prevention is tracking the approximate locations of cell phone users in West Africa who dial emergency call centers in an effort to predict the onset and spread of Ebola outbreaks

Nigeria Uses Android App With Facebook to Fight Ebola

After a two-month campaign surveillance campaign to track and reduce reporting times of ebola in Nigeria using a mobile phone app and Facebook, officials are confident the outbreak has been contained and that Nigeria will be declared ebola-free very soon. 

"Who Owns the Data? Opendata for Healthcare” – Summary of Roundtable Discussions

On July 1st, i-sense Director Rachel McKendry joined a prestigious panel to discuss the challenges surrounding open data in healthcare, as part of the UCL Festival for Digital Health. The event was closed, but a summary of discussions has been made available for the public. 

Ministers must stop unnecessary use of antibiotics in healthcare and farming

The UK Parliament Science and Technology Committee warn that, unless the Government sets clear responsibilities across all aspects of the NHS and veterinary medicine to achieve better stewardship of antimicrobial drugs, antibiotic resistance will continue to thrive.

WHO invites contributions to develop global action plan on antimicrobial resistance

The World Health Organisation (WHO) is inviting online contributions to the development of a global action plan to address antimicrobial resistance (AMR), as requested by the Sixty-seventh World Health Assembly in May 2014.

Bird flu 'danger zones' mapped

BBC reports on study led by Professor Simon Hay, which has developed a statistical model that accurately predicts the risk of H7N9 or "bird flu" infection in live-poulty markets across Asia.

Review: The Importance of Engineering and Physical Sciences to the Health and Life Sciences

An independent review, chaired by Professor Patrick Maxwell and attended by high-profile industry and academic figures, reports on the major role engineering and physical sciences has played in advancing health and life sciences

MPs takes evidence on Antimicrobial resistance (AMR)

The Commons Select Committee session focuses on the science of antimicrobial resistance, including why antimicrobial resistance has become so important, research avenues, the difference between clinical and other infection routes and questions surrounding the strategy.

Watch the video here

Aligning Incentives for Antibiotic Development and Use with Public Health Needs

Chatham House meeting Summary: Participants at this high-level roundtable discuss how to move forward with politically feasible schemes to incentivise drug development and more appropriate use of antibiotics.

Tackling Antibiotic Resistance for Greater Global Health Security

The Chatham House Briefing Paper discusses how we can integrate the expertise of academia, policy-makers, industry and interest groups to produce a global political response to the growing threat of antibiotic resistance

Linking syndromic surveillance with virological self-sampling

Study led by Public Health Engalnd's Maria Zambon investigates investigates whether self-swabbing by callers to NHS Direct could provide viable samples for influenza culture.

Back to top